Alvotech attending citi's global healthcare conference on december 4, 2024, and evercore's healthconx conference on december 5, 2024

Reykjavik, iceland, nov. 07, 2024 (globe newswire) -- alvotech (nasdaq: alvo), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in citi's 2024 global healthcare conference in miami, florida on december 4, 2024, and in evercore's healthconx conference in coral gables, florida on december 5, 2024. members of the management team will host one-on-one meetings at both conferences. alvotech will also hold a fire-side chat at evercore's healthconx conference on thursday, december 5, 2024 starting at 12:55 et (17:55 gmt).
ALVO Ratings Summary
ALVO Quant Ranking